2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73918):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-139128
    α-Methyl-DL-methionine 2749-07-7 98%
    α-Methyl-DL-methionine is a Methionine (HY-13694) derivative.
    α-Methyl-DL-methionine
  • HY-139135
    Methyl-L-NIO hydrochloride 150403-96-6 98%
    Methyl-L-NIO (compound 2d) hydrochloride is a potential selective inhibitor (IC50: 70 μM) of dimethylarginine dimethylaminohydrolase hDDAH. Methyl-L-NIO also has inhibitory activity against NO synthase. The inhibition rates of Methyl-L-NIO on different isoforms of NO synthase at a concentration of 100 μM are 77% (nNOS), 20% (eNOS), and 72% (iNOS) respectively; the inhibition rates at a concentration of 1 mM are 100% (nNOS), 85% (eNOS), 100% (iNOS).
    Methyl-L-NIO hydrochloride
  • HY-139138
    Naphthofluorescein di-(β-D-galactopyranoside) 133551-98-1 98%
    Naphthofluorescein di-(β-D-galactopyranoside) is a biochemical assay reagent.
    Naphthofluorescein di-(β-D-galactopyranoside)
  • HY-139143
    WWL154 1338574-93-8 98.96%
    WWL154, an analog of JZL184 that maintains the SH-reactive p-nitrophenyl carbamate group, is a FAAH-4 inhibitor.
    WWL154
  • HY-139166
    N-Palmitoyl-L-aspartate 1782-17-8 98%
    N-Palmitoyl-L-aspartate (N-Palmitoyl aspartic acid) is a chiral compound with properties of the aggregates formed in aqueous solution.
    N-Palmitoyl-L-aspartate
  • HY-139175
    ZLY032 2314465-67-1 98%
    ZLY032 is a dual FFA1/PPARδ agonist with the activity of improving glucose and lipid metabolism, alleviating liver fibrosis, and potentially inhibiting metabolic disorders.
    ZLY032
  • HY-139199
    4-Hydroxyphenylbutazone 16860-43-8 98%
    4-Hydroxyphenylbutazone is a metabolite of Phenylbutazone. Phenylbutazone, a nonsteroidal anti-inflammatory agent (NSAID), is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase (PHS).
    4-Hydroxyphenylbutazone
  • HY-139201C
    Poly-D-lysine hydrobromide (MW 1000-5000) 27964-99-4 98%
    Poly-D-lysine hydrobromide (MW 1000-5000) (PDLHB (MW 1000-5000)) is a synthetic cationic polypeptide polymer commonly used as a cell adhesion promoter and surface coating molecule. Poly-D-lysine hydrobromide is also known as a calcium-sensing receptor (CaSR) agonist peptide.
    Poly-D-lysine hydrobromide (MW 1000-5000)
  • HY-139235S
    N-Linolenoylethanolamine-d4 1451194-68-5 98%
    N-Linolenoylethanolamine-d4 is the deuterium labeled N-Linolenoylethanolamine.
    N-Linolenoylethanolamine-d4
  • HY-139251
    1-Myristoyl-2-palmitoyl-3-butyryl-rac-glycerol 1122578-89-5 98%
    1-Myristoyl-2-palmitoyl-3-butyryl-rac-glycerol is a triacylglycerol, which is composed of a myristic acid, a palmitic acid and a butyric acid. 1-Myristoyl-2-palmitoyl-3-butyryl-rac-glycerol is the component of human milk.
    1-Myristoyl-2-palmitoyl-3-butyryl-rac-glycerol
  • HY-139267
    (±)19(20)-EpDTE 1359721-83-7 98%
    (±)19(20)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid.
    (±)19(20)-EpDTE
  • HY-139268
    (±)7(8)-EpDTE 1616607-36-3 98%
    (±)7(8)-EpDTE is an oxylipin and an oxidative metabolite of docosapentaenoic acid.
    (±)7(8)-EpDTE
  • HY-13927R
    Acetildenafil (Standard) 831217-01-7
    Acetildenafil (Standard) is the analytical standard of Acetildenafil. This product is intended for research and analytical applications. Acetildenafil is a structural analog of Sildenafil (HY-15025). Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor.
    Acetildenafil (Standard)
  • HY-139312S
    L-Mannitol-1-13C 98%
    L-Mannitol-1-13C is the 13C labeled L-Mannitol. L-mannitol is a compound?can be used for ?the compound sweetener synthesis.
    L-Mannitol-1-13C
  • HY-139322
    PEG-8 laurate 35179-86-3 98%
    PEG-8 laurate is a single chain surfactant. PEG-8 laurate reduces the skin barrier, and acts as a penetration enhancer. PEG-8 laurate can be used to synthesize elastic vesicles.
    PEG-8 laurate
  • HY-139325
    NHS-Modified MMAF 1404073-10-4 98%
    NHS-Modified MMAF (WO2012143499A2, intermediat 210) is an intermediate which can be used for producing the anti-mesothelin binder-agent conjugates (ADCs).
    NHS-Modified MMAF
  • HY-139364
    mPGES1-IN-4 2253745-78-5 98%
    mPGES1-IN-4 (compound 32) is a polysubstituted pyrimidine compound and a submicromolar PGE2 production inhibitor. It exerts its anti-inflammatory effect mainly by inhibiting mPGES-1 and has a significant inhibitory effect on the acute inflammation model in vivo.
    mPGES1-IN-4
  • HY-139365
    mPGES1-IN-5 2253745-70-7 98%
    mPGES1-IN-5 (compound 18) is a polysubstituted pyrimidine compound and a submicromolar PGE2 production inhibitor. It exerts its anti-inflammatory effect mainly by inhibiting mPGES-1 and has a significant inhibitory effect on the acute inflammation model in vivo.
    mPGES1-IN-5
  • HY-139386
    15β-Travoprost 1420791-14-5 98%
    15β-Travoprost (15(S)-Flu-Ipr) is an enantiomer of Travoprost (HY-B0584). Travoprost, an isopropyl ester proagent, is a high affinity, selective FP prostaglandin full receptor agonist.
    15β-Travoprost
  • HY-139391
    (±)10(11)-DiHDPA 1345275-22-0 98%
    (±)10(11)-DiHDPA is a fatty acid diol and a metabolite of epoxidized fatty acids (EpFAs).
    (±)10(11)-DiHDPA